Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001493152-25-003386·LoConti Joseph E.
Schedule 13D ownership disclosure
VITALITY BIOPHARMA
COMMON STOCK · CUSIP: 92849B107
Event date: 2025-01-21
- Filing-level shares
- 24,184,456.00
- Percent of class
- 22.4%
- Joseph E. LoContiReported CIK 0001025708
Shares: 24,184,456.00 · Class: 22.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-25-003386
- Form type
- SCHEDULE 13D/A
- Filer
- LoConti Joseph E.
- CIK
- CIK 1025708
- Filed
- Jan 23, 2025
- Reporting period
- Jan 21, 2025
- Description
- Schedule 13D beneficial ownership